Multiple sclerosis

Last updated: July 13, 2026

Multiple sclerosis

Annie

Annie

Class I antiarrhythmics: Sodium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Atrioventricular nodal reentrant tachycardia (AVNRT)
Cyanotic congenital heart defects: Pathology review
Ventricular septal defect
Acyanotic congenital heart defects: Pathology review
Patent ductus arteriosus
Myocardial infarction
Angina pectoris
Tricuspid valve disease
Mitral valve disease
Pulmonary valve disease
Aortic valve disease
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
Dilated cardiomyopathy
Cardiac tamponade
Endocarditis
Rheumatic heart disease
Myocarditis
Cardiomyopathies: Pathology review
Valvular heart disease: Pathology review
Stable angina
Unstable angina
Prinzmetal angina
Pericarditis and pericardial effusion
Pericardial disease: Pathology review
Vasculitis
Atrial flutter
Coronary artery disease: Pathology review
Coronary circulation
Heart failure: Pathology review
Changes in pressure-volume loops
Syncope: Clinical
Hypoxia
Respiratory system anatomy and physiology
Corynebacterium diphtheriae (Diphtheria)
Moraxella catarrhalis
Influenza virus
Upper respiratory tract infection
Rhinovirus
Adenovirus
Epstein-Barr virus (Infectious mononucleosis)
Respiratory syncytial virus
Renal tubular acidosis: Pathology review
Plasma anion gap
Nephritic syndromes: Pathology review
Hyponatremia: Clinical
Hyponatremia
Spinal cord disorders: Pathology review
Somatosensory receptors
Somatosensory pathways
Introduction to the immune system
MHC class I and MHC class II molecules
Cell-mediated immunity of CD4 cells
Chewing and swallowing
Anatomy of the larynx and trachea
Pharyngeal arches, pouches, and clefts
Development of the face and palate
Anatomy of the pharynx and esophagus
Pemphigus vulgaris
Wernicke-Korsakoff syndrome
Anatomy of the limbic system
Olfactory transduction and pathways
Cerebellum
Basal ganglia: Direct and indirect pathway of movement
Typical antipsychotics
Atypical antipsychotics
Multiple sclerosis
Alzheimer disease
Creutzfeldt-Jakob disease
Huntington disease
Meningitis
Encephalitis
Rabies virus
Anatomy of the anterolateral abdominal wall
Anatomy of the abdominal viscera: Blood supply of the foregut, midgut and hindgut
Anatomy of the abdominal viscera: Esophagus and stomach
Anatomy of the abdominal viscera: Small intestine
Anatomy of the abdominal viscera: Large intestine
Anatomy of the abdominal viscera: Pancreas and spleen
Anatomy of the gastrointestinal organs of the pelvis and perineum
Anatomy clinical correlates: Anterior and posterior abdominal wall
Megaloblastic anemia
Small intestine histology
Colon histology
Diverticular disease: Pathology review
Gastroschisis
Imperforate anus
Omphalocele
Meckel diverticulum
Intestinal atresia
Hirschsprung disease
Intestinal malrotation
Necrotizing enterocolitis
Intussusception
Tropical sprue
Small bowel bacterial overgrowth syndrome
Celiac disease
Short bowel syndrome (NORD)
Lactose intolerance
Whipple's disease
Protein losing enteropathy
Microscopic colitis
Crohn disease
Ulcerative colitis
Bowel obstruction
Intestinal adhesions
Volvulus
Gallstone ileus
Abdominal hernias
Femoral hernia
Inguinal hernia
Small bowel ischemia and infarction
Ischemic colitis
Familial adenomatous polyposis
Peutz-Jeghers syndrome
Gardner syndrome
Juvenile polyposis syndrome
Colorectal polyps
Colorectal cancer
Carcinoid syndrome
Irritable bowel syndrome
Gastroenteritis
Diverticulosis and diverticulitis
Appendicitis
Anal fissure
Anal fistula
Hemorrhoid
Rectal prolapse
Carbohydrates and sugars
Diabetes insipidus
Diabetes mellitus
Diabetes insipidus and SIADH: Pathology review
Diabetes mellitus: Pathology review
Hyperaldosteronism
Waterhouse-Friderichsen syndrome
Primary adrenal insufficiency
Anatomy and physiology of the male reproductive system

Flashcards

Multiple sclerosis

0 of 13 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 4 complete

Start
A 30-year-old man comes to the PA complaining of numbness in the upper extremities that started several days ago. The patient has no significant past medical history, but he did have an episode of trigeminal neuralgia 4 months ago, which resolved spontaneously. He does not have any urinary incontinence, but he mentions that he took fiber supplements last year due to several weeks of constipation that “resolved on its own.” Temperature is 37.0°C (98.6°F), pulse is 82/min, respirations are 15/min, and blood pressure is 125/75 mmHg. Physical examination shows decreased vibratory and positional sensation in both upper extremities but no other sensory loss. An MRI is performed and shows multiple periventricular plaques, as demonstrated in the following:



Image reproduced from Radiopedia


The patient is prescribed glatiramer acetate. This medication is likely to prevent future exacerbations of this patient’s condition via which of the following mechanisms? 

Transcript

Watch video only

Content Reviewers

Multiple sclerosis is a demyelinating disease of the central nervous system, which includes the brain and the spinal cord.

Myelin is the protective sheath that surrounds the axons of neurons, allowing them to quickly send electrical impulses.

This myelin is produced by oligodendrocytes, which are a group of cells that support neurons.

In multiple sclerosis, demyelination happens when the immune system inappropriately attacks and destroys the myelin, which makes communication between neurons break down, ultimately leading to all sorts of sensory, motor, and cognitive problems.

Now, the brain, including the neurons in the brain, is protected by things in the blood by the blood brain barrier, which only lets certain molecules and cells through from the blood.

For immune cells like T and B cells that means having the right ligand or surface molecule to get through the blood brain barrier, this is kind of like having the a VIP pass to get into an exclusive club.

Once a T cell makes its way in it can get activated by something it encounters - in the case of multiple sclerosis, it’s activated by myelin.

Once the T-cell gets activated, it changes the blood brain barrier cells to express more receptors, and this allows immune cells to more easily bind and get in, it’s kind of like bribing the bouncer to let in a lot of people.

Now, multiple sclerosis is a type IV hypersensitivity reaction, or cell-mediated hypersensitivity. And this means that those myelin specific T-cells release cytokines like IL-1, IL-6, TNF-alpha, and interferon-gamma, and together dilate the blood vessels which allows more immune cells to get in, as well as directly cause damage to the oligodendrocytes.

The cytokines also attract B-cells and macrophages as part of the inflammatory reaction.

Those B-cells begin to make antibodies that mark the myelin sheath proteins, and then the macrophages use those antibody markers to engulf and destroy the oligodendrocytes.

Without oligodendrocytes, there’s no myelin to cover the neurons, and this leaves behind areas of scar tissue, also called plaques or sclera.

In multiple sclerosis, these immune attacks typically happen in bouts.

In other words, an autoimmune attack on the oligodendrocytes might happen, and then regulatory T cells will come in to inhibit or calm down the other immune cells, leading to a reduction in the inflammation.

Early on in multiple sclerosis, the oligodendrocytes will heal and extend out new myelin to cover the neurons, which is a process called remyelination.

Unfortunately, though, over time as the oligodendrocytes die off the remyelination stops and the damage becomes irreversible with the loss of axons.

Just like other autoimmune diseases, the exact cause of multiple sclerosis is unknown, but is linked to both genetic and environmental factors.

Genetic risk factors include being a woman and having genes that encode a specific type of immune molecule called HLA-DR2 which is used to identify and bind to foreign molecules.

Environmental risk factors might include infections as well as vitamin D deficiency, which is an interesting one because it might help explain why the rates of multiple sclerosis are higher at the northern and southern poles compared to the equator where there’s a lot more sunlight.

Together these genetic and environmental influences might lead to the body not killing off immune cells that target myelin.

So it turns out that there are four main types of multiple sclerosis based on the pattern of symptoms over time. To break this down, we can use this graph with time on the x-axis, where time refers to the lifespan of the individual, and disability on the y-axis.

The first, and by far the most common pattern of multiple sclerosis, is called relapsing-remitting multiple sclerosis or RRMS. This condition is what we just described, bouts of autoimmune attacks happening months, or even years, apart, and causing an increase in the level of disability.

For example, during a bout a person may lose some vision, but then it may be followed by improvement if there’s remyelination.

Unfortunately, though, more often than not, the remyelination process is not complete so there is often some residual disability that remains, and that means that with each attack, more and more of the central nervous system gets irreversibly damaged.

In the relapsing-remitting multiple sclerosis type there’s typically no increase in disability between bouts, so the line stays flat during that time.

Now, the second type is called secondary progressive multiple sclerosis or SPMS which initially is pretty similar to the relapse-remitting type, but over time the immune attack becomes constant which causes a steady progression of disability.

The third type is primary-progressive multiple sclerosis or PPMS, which is basically one constant attack on myelin which causes a steady progression of disability over a person’s lifetime.

The final type is progressive relapsing multiple sclerosis or PRMS, which is also one constant attack but this time there are bouts superimposed during which the disability increases even faster.

Specific symptoms varying a lot from person to person, and largely depend on the location of the plaques.

Key Takeaways

Multiple sclerosis is a progressive, demyelinating disease on the central nervous system, characterized by the destruction of myelin, the protective sheath surrounding nerve cells, as well as inflammation and scarring of nerve fibers.

Damage to these nerves disrupts the ability of parts of the nervous system to transmit impulses, resulting in a wide range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Symptoms vary widely, but they may include muscle weakness, fatigue, vision problems, balance and coordination problems, and problems with memory and thinking.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine" McGraw Hill Education/ Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw Hill Professional (2019)
  5. "Multiple sclerosis" The Lancet (2008)
  6. "Defining the clinical course of multiple sclerosis: Results of an international survey" Neurology (1996)